Now I have read the full paper and can verify the reviewers' claims. Let me write the consolidated final review.

---

## Summary

HYPOGENEAGENT is an LLM-driven framework for selecting the resolution hyperparameter in Leiden/Louvain clustering of single-cell Perturb-seq data. The core idea is to run a frontier LLM (GPT-o3) over each cluster's gene signature, elicit up to five ranked GO hypotheses per cluster, embed those hypotheses with a sentence encoder, and compute intra-cluster agreement (ICS) and inter-cluster distinctiveness (ICD). These are combined into a single Resolution Score whose argmax is taken as the optimal resolution. The method is evaluated on one K562 CRISPRi Perturb-seq dataset and compared qualitatively to silhouette score, modularity, and functional enrichment analysis.

---

## Strengths

- **Concrete, formal metric definitions**: Table 1 and Section 3.4 give well-specified formulas for ICS, ICD, and the Resolution Score. The formulation is clear and reusable, and the idea of optimizing cluster coherence via annotation consistency is genuinely novel in the single-cell resolution-selection literature.

- **Systematic Stage 1 LLM ablation**: Sections 4.2–4.3 systematically vary LLM backbone (GPT-4o, GPT-o3, GPT-5, Gemini variants), embedding method (OpenAI, SapBERT, Nomic), prompt design (general V1/V2 vs. hypothesis), and temperature across 100 non-redundant GOBP gene sets. This is a substantive benchmarking effort that yields a principled configuration choice (GPT-o3 + hypothesis prompt + OpenAI embedding) before any Stage 2 deployment.

- **Dual-modality application**: The framework is applied to both gene-expression-level clustering (GEX) and perturbation-level clustering (CRISPR-guide groups), yielding consistent Resolution Score optima (r=0.4 and r=0.5 respectively), showing the metric is not tied to a single input modality.

- **Self-consistency validation of GPT-o3**: Figure S3 shows that GPT-o3's own confidence scores correlate well with cosine-similarity-based semantic accuracy, providing evidence that the model is internally calibrated rather than generating arbitrary rankings.

---

## Weaknesses

### Fatal

*None that are fully verifiable as fatal from the page alone.*

### Major

- **Core comparative claim is not demonstrated.** The abstract states the Resolution Score "selects clustering granularities that exhibit alignment with known pathway compared to classical metrics," and Section 1 asserts it "selects parameter settings that recover known perturbation effects better than modularity and silhouette criteria." But no independent ground truth for the correct resolution is provided. The comparison reduces to: HYPOGENEAGENT picks r=0.4, modularity peaks at r=0.7, silhouette elbows at r=0.5–0.6, and the agent-selected partition looks reasonable on a UMAP. This does not demonstrate superiority — it demonstrates a different choice. Without an external criterion (e.g., recall of known pathway co-clusterings from the Replogle et al. perturbation phenotype literature), the comparative claim cannot be evaluated. The word "superior" in the conclusion ("demonstrating superior biological interpretability compared with traditional metrics") is not supported by any experiment in the paper.

- **The "external validation" via functional enrichment analysis is both circular and contradictory.** Section 4.4.3 applies the same ICS/ICD framework to GO enrichment results and presents this as validation of HYPOGENEAGENT. However, both pipelines measure how internally coherent and mutually distinct the functional descriptions of clusters are — they are not independent signals. More concretely, the Figure 6 caption explicitly states: *"In (a), the resolution score peaks at 0.7."* But HYPOGENEAGENT selected r=0.4. The text reconciles this by invoking "the reasonability of cluster numbers we expected, so the selected resolution can be 0.5 or 0.4," which is a post-hoc, undefined criterion that is not operationalized anywhere in the paper. The one method offered as partial external support actually disagrees with the agent's primary selection, and this discrepancy is not scientifically resolved.

- **Single-dataset evaluation.** The entire Stage 2 evaluation rests on one K562 CRISPRi Perturb-seq dataset. Even as a preliminary test, this is insufficient to establish that the Resolution Score generalizes across cell types, experimental platforms, or perturbation contexts. The paper acknowledges this in the conclusion but still makes sweeping claims about the method being a "general-purpose tool for single-cell, perturb-seq and multi-omics analyses."

### Minor

- **Hyperparameter w=1/3 is selected via grid search on the only test dataset.** Section 3.4 states: *"w = 1/3 ... was chosen by a small grid search and found to give a stable ordering of resolutions across data sets."* But there is only one Stage 2 dataset. The phrase "across data sets" is not substantiated by any second dataset. Figure S5 shows how the Resolution Score changes with w for individual clusters but does not constitute an independent validation. Reporting ICS and ICD components separately throughout — rather than just the combined score — would allow readers to assess whether the weighting actually matters.

- **ICD may reward linguistic diversity rather than biological distinctiveness.** The ICD metric (Section 3.4) measures cosine dissimilarity between clusters' top-hypothesis text embeddings. If the LLM uses varied vocabulary for biologically similar processes (or uniform vocabulary for distinct ones), ICD is systematically biased. No analysis of this confound is provided, though it would be addressable with a simple sanity check on synthetic gene sets.

- **Stage 1 benchmark has a data-contamination concern.** The 100 GOBP gene sets and their official descriptions are likely present in LLM training data. Measuring cosine similarity between an LLM-generated description and the official GO term text therefore confounds genuine biological reasoning with verbatim or near-verbatim retrieval. This does not invalidate Stage 2 but means Stage 1 overstates the model's biological reasoning ability. A brief discussion of this limitation is warranted.

### Trivial

- The description of Figure 6's resolution score peaking at r=0.7 versus the main method selecting r=0.4 is never explicitly reconciled in the text; a single clarifying sentence would remove potential confusion.

---

## Nice-to-Haves

- **Ground-truth experiment**: Map clusters at each resolution to known pathway memberships from the Replogle et al. dataset (e.g., known DNA-repair, cell-cycle gene co-essential modules), compute recall at each resolution, and show that HYPOGENEAGENT's selected resolution maximizes this recall. This single experiment would transform the comparative claim from assertion to demonstration.
- **A second dataset**: Even a small, publicly available mouse or human dataset with characterized perturbation groupings would establish generalizability and remove the single-dataset limitation.
- **Report API costs** for a full resolution sweep (10 resolutions × ~20 clusters × 5 hypotheses per cluster with GPT-o3), as this is a practical constraint directly relevant to the stated goal of scalable deployment.
- Reporting ICS and ICD separately (not only the combined RS) throughout Figures 3 and 4 would make the contribution of each component transparent to readers.

---

## Removed Points

*These points are flagged to be removed; treat them with caution.*

- **Harsh Critic: GPT-5 instability requires full explanation.** The critic argues that GPT-5 underperforming GPT-o3 "deserves more than a single clause." Section 4.3 does address this ("GPT-5 performs good but not as stable as expected"), and the model selection consequence (using GPT-o3) is clearly justified. The depth of discussion is a matter of presentation preference, not a scientific flaw.

- **Harsh Critic: Scalability is a prerequisite, not future work.** This is scope-creep criticism. The paper explicitly frames Stage 2 as a "preliminary test" in the abstract; critiquing the absence of large-scale experiments is legitimate but belongs in nice-to-haves, not as a major flaw of the current submission.

- **Strength Finder: "UMAP shows clean separation" as direct evidence of superiority.** The UMAP at r=0.4 shows well-separated clusters, but this is qualitative and cannot independently confirm superiority over other resolutions. Removed as a standalone strength since it conflicts with the verified weakness that no objective comparison is made.

- **Strength Finder: "Empirical demonstration of biological alignment versus traditional metrics."** The strength claim that HYPOGENEAGENT's choice "yields clusters validated by functional enrichment analysis... whereas traditional metrics favour different, less biologically coherent partitions" is not supported: the enrichment analysis actually peaks at r=0.7, not r=0.4. This strength conflicts with a verified weakness and is therefore removed.

---

## Novel Insights

The paper's core observation — that LLM annotation self-consistency (both intra-cluster and inter-cluster) can be operationalized as a proxy for biological clustering quality — is a genuinely novel framing. Using an LLM as a "referee panel" that scores partitions by semantic coherence of its own outputs, rather than by any distance-based statistic, is an interesting paradigm shift. The Stage 1 finding that GPT-o3 confidence scores correlate with semantic accuracy (Figure S3) provides early evidence that LLM self-calibration is real and could support automated quality control in annotation pipelines more broadly. However, these insights remain preliminary given the evaluation's scope.

---

## Suggestions

1. **Construct an independent resolution ground truth**: Use the known functional groupings of perturbed genes from Replogle et al. to compute recall of known pathway co-clustering at each resolution. This is the single highest-value experiment the authors can run to validate the central claim.
2. **Apply to a second dataset**: Any publicly available Perturb-seq or scRNA-seq dataset with characterized cell-type or perturbation groupings. This resolves the single-dataset limitation and validates w=1/3 independently.
3. **Reconcile Figure 6 vs. HYPOGENEAGENT discrepancy**: Either re-examine why enrichment-based scoring peaks at r=0.7 while the agent peaks at r=0.4, or reframe Section 4.4.3 honestly as partial disagreement rather than validation.
4. **Report ICS and ICD separately in addition to the combined RS**, so the contribution of each component is transparent.
5. **Add a brief discussion of the GO-text contamination concern in Stage 1**, acknowledging that high cosine similarity scores may partly reflect LLM memorization.

---

## Score and Decision

**Originality**: The application of LLM annotation self-consistency as a resolution-selection criterion is novel. The individual components (ICS, ICD, LLM annotation) are not individually new, but their combination for this purpose is original. *Score: 3/5*

**Importance of research question**: Resolution selection in single-cell clustering is a genuine and widespread pain point. Automating it in a biologically informed way is a valuable goal. *Score: 4/5*

**Claims supported**: The central comparative claim ("selects parameter settings that recover known perturbation effects better than modularity and silhouette criteria") is not demonstrated by any experiment with an independent ground truth. The only "external" validation is circular and contradicts the method's primary selection. *Score: 1/5*

**Soundness of experiments**: Stage 1 is methodologically reasonable (systematic ablation with 100 labeled sets). Stage 2 is limited to one dataset, the validation is circular, and the key hyperparameter is tuned on the test data. *Score: 2/5*

**Clarity of writing**: The paper is reasonably written; the agent workflow and metric definitions are clear. The Figure 6 / Section 4.4.3 discrepancy is confusing and unaddressed. *Score: 3/5*

**Value to research community**: The framework is a promising preliminary contribution, but the current evidence is insufficient to establish it as a validated tool. As a system description and early exploration, it has some value, but the overclaimed comparative results reduce confidence. *Score: 2/5*

The core idea is interesting and the Stage 1 ablation is carefully executed, but the paper's headline comparative claim — the contribution that distinguishes it from a tool paper — is not demonstrated. The "external validation" is circular and disagrees with the method's own selection. A single dataset with no independent ground truth cannot establish superiority. The paper reads as a system description and preliminary analysis rather than a validated methodology, and the introduction and conclusion overclaim relative to what the experiments support.

MY FINAL SCORE: <score>3.0</score>
MY FINAL DECISION: <decision>Reject</decision>

<subscores>
<originality>3</originality>
<importance>4</importance>
<claims_supported>1</claims_supported>
<soundness>2</soundness>
<clarity>3</clarity>
<community_value>2</community_value>
</subscores>